Form 4: MindMed's Chief Medical Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Dan Karlin, Chief Medical Officer of Mind Medicine (MindMed) Inc., sold 6,925 common shares on June 25, 2024, to satisfy withholding tax obligations related to vested restricted stock units.
Summary
- On June 25, 2024, Dan Karlin, the Chief Medical Officer of Mind Medicine (MindMed) Inc., sold 6,925 common shares.
- The shares were sold at a weighted average price of $7.22.
- The sale was executed to cover withholding tax obligations associated with the settlement of vested restricted stock units.
- The transaction was conducted under a pre-arranged Rule 10b5-1 plan adopted on June 14, 2022.
- Following the transaction, Karlin still beneficially owns 351,527 common shares.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover tax obligations) by an executive, which is neither particularly positive nor negative.
Industry Context
Sales of shares by company insiders are a common occurrence, often related to compensation or tax obligations. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on current market information.
Stakeholder Impact
- The sale of shares by a company officer could have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| June 14, 2022 | Date of adoption of Rule 10b5-1 plan |
| June 25, 2024 | Date of transaction (sale of shares) |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.